Feedback / Questions
MM 111 - Merrimack
Merrimack Pharma: J.P. Morgan Healthcare Conference
(Merrimack)
-
Jan 29, 2013 -
"MM-111 + Multiple Combination Regimens Phase 1 HER2+ Patients in Multiple Solid Tumors"
P1 data
•
Oncology
http://www.larvolonline.com/tlg/ccdb/MerrimackPharmaJPMorganHealthcareConferenceJan082013.pdf
Jan 29, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious